|
Site Search
|
Oculus Announces SFDA Approval of Microcyn
publication date: Mar 31, 2008
Oculus Innovative Sciences has received an approval from the SFDA of its Microcyn® Technology for treatment of several acute and chronic wounds including ulcers, cuts, contusions and burns. Microcyn is a super-oxygenated form of water that is not toxic, but highly effective against bacteria, viruses, mold and spores. Microcyn combines its anti-infective properties with the ability to promote wound healing. More details...
Stock Symbol: (NSDQ: OCLS)
|
Partner Events
September 16-18, 2008
San Francisco, CA
October 11-13, 2008
Dalian, China
November 9-11, 2008
Shanghai, China
>> More details...
|